How do you diagnose insulin resistance in a laboratory setting?

Laboratory Assessment of Insulin Resistance

The most practical approach to diagnosing insulin resistance in clinical practice is measuring fasting plasma insulin levels (>15 mU/L indicates insulin resistance) combined with fasting plasma glucose (100-125 mg/dL suggests impaired fasting glucose), supplemented by HbA1c (5.7-6.4% indicates prediabetes). 1, 2

Primary Diagnostic Tests

Fasting Plasma Insulin

• Normal: <15 mU/L
• Borderline high: 15-20 mU/L
• High (insulin resistance): >20 mU/L 1, 2, 3
• Must be drawn after minimum 8-hour overnight fast 4, 1
• Directly confirms insulin resistance when elevated 2

Fasting Plasma Glucose (FPG)

• Impaired fasting glucose: 100-125 mg/dL (5.6-6.9 mmol/L) indicates insulin resistance 1, 2
• Diagnostic threshold for diabetes: ≥126 mg/dL (7.0 mmol/L) 4
• Should be measured in venous plasma in an accredited laboratory 4
• Blood drawn in morning after 8-14 hour overnight fast 4

Hemoglobin A1c (HbA1c)

• Prediabetes range: 5.7-6.4% (39-47 mmol/mol) suggests underlying insulin resistance 1, 2
• Values >6.0% indicate high risk requiring aggressive intervention 2
• Diabetes diagnosis: ≥6.5% 4

Oral Glucose Tolerance Test (OGTT)

• 2-hour glucose 140-199 mg/dL (7.8-11.0 mmol/L) indicates impaired glucose tolerance and insulin resistance 1, 2
• Performed with 75-g glucose load after overnight fast 4
• Patient remains seated and does not smoke during test 4

Comprehensive Laboratory Panel

Lipid Profile Assessment

• HDL cholesterol <35 mg/dL suggests insulin resistance 2
• Triglycerides >250 mg/dL indicates insulin resistance 2
• Combined fasting insulin and triglycerides provide enhanced screening sensitivity 5

C-Peptide Measurement

• Helps differentiate endogenous insulin production from exogenous administration 1
• Simultaneous elevation of insulin and C-peptide confirms endogenous hyperinsulinism (insulin resistance) 1
• Isolated elevated C-peptide without hypoglycemia reflects insulin resistance rather than pathological hyperinsulinism 1, 2

Who Should Be Tested

High-Risk Populations Requiring Screening

• BMI ≥25 kg/m² (or ≥23 kg/m² for Asian Americans) with additional risk factors 1, 2, 3
• First-degree relative with type 2 diabetes 1, 2
• High-risk ethnicity: American Indian, African American, Hispanic/Latino, Asian/Pacific Islander 1, 2, 3
• Physical signs: acanthosis nigricans, central obesity, skin tags 1, 2, 3
• Associated conditions: hypertension, dyslipidemia, polycystic ovary syndrome, history of gestational diabetes 1, 2, 3
• Physical inactivity 2

Critical Testing Considerations

Proper Testing Conditions

• Always perform in fasting state (minimum 8 hours) to avoid postprandial variations 1, 2, 3
• Use venous plasma samples, not capillary blood 4
• Collect in tube containing glycolytic inhibitor (granulated citrate buffer) or immediately place in ice-water slurry 4
• Document medications affecting glucose metabolism when interpreting results 1

Common Pitfalls to Avoid

• Normal glucose levels do not exclude insulin resistance—hyperinsulinemia can exist with euglycemia 2
• Stress hyperglycemia during acute illness temporarily mimics insulin resistance and should not be used for diagnosis 1
• Fasting insulin alone may miss some cases; QUICKI or combined insulin-triglyceride scores may be more sensitive 6, 7

Interpreting Results

Confirming Insulin Resistance

• Presence of impaired fasting glucose (100-125 mg/dL) OR impaired glucose tolerance (2-hour OGTT 140-199 mg/dL) indicates prediabetes with likely insulin resistance 1, 2
• Elevated fasting insulin (>15 mU/L) directly confirms insulin resistance 1, 2
• HbA1c 5.7-6.4% suggests prediabetes with underlying insulin resistance 1, 2

Physical Examination Findings

• Look for acanthosis nigricans (hyperpigmented, velvety skin in body folds) 1, 2
• Assess for central/visceral adiposity and measure waist circumference 2
• Check blood pressure for hypertension 1, 3

Population-Specific Thresholds

• Asian Americans: Use BMI ≥23 kg/m² threshold (versus ≥25 kg/m² for general population) due to increased diabetes risk at lower BMI 2
• African Americans may have equivalent diabetes risk at BMI 26 kg/m² compared to BMI 30 kg/m² in non-Hispanic whites 2

Gold Standard (Research Only)

The hyperinsulinemic-euglycemic clamp remains the gold standard for measuring insulin sensitivity but is impractical for clinical use due to complexity, cost, and time requirements 3. It is reserved for research settings only.

budget:budget_used 17934 16501 1433